Carol E. Green

2.9k total citations
55 papers, 2.2k citations indexed

About

Carol E. Green is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Carol E. Green has authored 55 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Molecular Biology and 15 papers in Pharmacology. Recurrent topics in Carol E. Green's work include Drug Transport and Resistance Mechanisms (16 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Cancer therapeutics and mechanisms (6 papers). Carol E. Green is often cited by papers focused on Drug Transport and Resistance Mechanisms (16 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Cancer therapeutics and mechanisms (6 papers). Carol E. Green collaborates with scholars based in United States, Japan and United Kingdom. Carol E. Green's co-authors include Charles A. Tyson, Yuichi Sugiyama, Noriaki Shimada, Hiroshi Suzuki, Takafumi Iwatsubo, Noriko Hirota, Takashi Ishizaki, Kan Chiba, Jack E. Dabbs and Tsuyoshi Ooie and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Carol E. Green

53 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol E. Green United States 25 680 551 541 415 281 55 2.2k
Bertrand Rochat Switzerland 31 740 1.1× 590 1.1× 910 1.7× 288 0.7× 400 1.4× 57 3.0k
Toshiro Niwa Japan 27 1.1k 1.6× 505 0.9× 452 0.8× 345 0.8× 258 0.9× 98 2.2k
Don K. Walker United Kingdom 22 385 0.6× 309 0.6× 631 1.2× 374 0.9× 216 0.8× 40 2.2k
Pankaj B. Desai United States 29 545 0.8× 657 1.2× 715 1.3× 318 0.8× 142 0.5× 81 3.1k
Adedayo Adedoyin United States 21 559 0.8× 329 0.6× 393 0.7× 277 0.7× 262 0.9× 62 1.7k
Kimberly K. Adkison United States 21 435 0.6× 606 1.1× 368 0.7× 404 1.0× 142 0.5× 42 1.7k
Ruth Hyland United Kingdom 24 1.5k 2.2× 734 1.3× 639 1.2× 406 1.0× 300 1.1× 31 2.5k
Michael H. Tarbit United Kingdom 27 931 1.4× 434 0.8× 457 0.8× 443 1.1× 230 0.8× 43 2.3k
Alexander Jetter Switzerland 29 924 1.4× 648 1.2× 467 0.9× 363 0.9× 325 1.2× 76 2.9k
Nuggehally R. Srinivas India 32 488 0.7× 506 0.9× 903 1.7× 179 0.4× 654 2.3× 254 3.4k

Countries citing papers authored by Carol E. Green

Since Specialization
Citations

This map shows the geographic impact of Carol E. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol E. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol E. Green more than expected).

Fields of papers citing papers by Carol E. Green

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol E. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol E. Green. The network helps show where Carol E. Green may publish in the future.

Co-authorship network of co-authors of Carol E. Green

This figure shows the co-authorship network connecting the top 25 collaborators of Carol E. Green. A scholar is included among the top collaborators of Carol E. Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol E. Green. Carol E. Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gibbs, Seth, Carol E. Green, Lalitha Iyer, et al.. (2023). Granulocyte Colony-Stimulating Factor (Neupogen®; Filgrastim) Accelerates Neutrophil Recovery in a Rodent Model of Sulfur Mustard-Induced Hematologic Toxicity. Disaster Medicine and Public Health Preparedness. 17. e550–e550.
2.
Tang, Liang, Robert R. Swezey, Carol E. Green, & Jon C. Mirsalis. (2022). Enhancement of sensitivity and quantification quality in the LC–MS/MS measurement of large biomolecules with sum of MRM (SMRM). Analytical and Bioanalytical Chemistry. 414(5). 1933–1947. 12 indexed citations
3.
Tang, Liang, Robert R. Swezey, Carol E. Green, et al.. (2022). A tandem liquid chromatography and tandem mass spectrometry (LC/LC–MS/MS) technique to separate and quantify steroid isomers 11β-methyl-19-nortestosterone and testosterone. Journal of Chromatography B. 1193. 123165–123165. 7 indexed citations
4.
DeWald, Lisa Evans, Joshua C. Johnson, Elena Postnikova, et al.. (2019). In Vivo Activity of Amodiaquine against Ebola Virus Infection. Scientific Reports. 9(1). 20199–20199. 13 indexed citations
5.
Wang, Jing‐Hung, Aaron N. Endsley, Carol E. Green, & A. Matin. (2016). Utilizing native fluorescence imaging, modeling and simulation to examine pharmacokinetics and therapeutic regimen of a novel anticancer prodrug. BMC Cancer. 16(1). 524–524. 7 indexed citations
6.
Velez‐Carrasco, Wanda, Carol E. Green, Paul Catz, et al.. (2015). Pharmacokinetics and Metabolism of 4R-Cembranoid. PLoS ONE. 10(3). e0121540–e0121540. 16 indexed citations
7.
Sammeta, Srinivasa M., Li Wang, Kathleen O’Loughlin, et al.. (2013). Formulation approaches to improving the delivery of an antiviral drug with activity against seasonal flu. Pharmaceutical Development and Technology. 20(2). 169–175. 3 indexed citations
8.
Madrid, Peter B., Sidharth Chopra, Ian D. Manger, et al.. (2013). A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents. PLoS ONE. 8(4). e60579–e60579. 188 indexed citations
9.
10.
Green, Carol E., Robert R. Swezey, James Bakke, et al.. (2010). Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent. Cancer Chemotherapy and Pharmacology. 67(5). 995–1006. 8 indexed citations
11.
Coughlin, John E., Seetharamaiyer Padmanabhan, Chandrika P. Govardhan, et al.. (2010). Orally bioavailable anti-HBV dinucleotide acyloxyalkyl prodrugs. Bioorganic & Medicinal Chemistry Letters. 20(5). 1783–1786. 6 indexed citations
12.
Furimsky, Anna, Carol E. Green, Paul Catz, et al.. (2007). Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1. Drug Metabolism and Disposition. 36(1). 129–136. 22 indexed citations
13.
14.
Wheelock, Craig E., Åsa M. Wheelock, Rong Zhang, et al.. (2003). Evaluation of α-cyanoesters as fluorescent substrates for examining interindividual variation in general and pyrethroid-selective esterases in human liver microsomes. Analytical Biochemistry. 315(2). 208–222. 43 indexed citations
15.
Green, Carol E., et al.. (2001). Analysis of 2β-carbomethoxy-3β-(4-fluorophenyl)-N-(3-iodo-E-allyl)nortropane in rat plasma. Journal of Chromatography A. 924(1-2). 471–481. 4 indexed citations
16.
Hirota, Noriko, Kiyomi Ito, Takafumi Iwatsubo, et al.. (2001). In Vitro/in Vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans. Biopharmaceutics & Drug Disposition. 22(2). 53–71. 59 indexed citations
17.
Kanamitsu, Shin‐ichi, Kiyomi Ito, Carol E. Green, et al.. (2000). Prediction of In Vivo Interaction Between Triazolam and Erythromycin Based on In Vitro Studies Using Human Liver Microsomes and Recombinant Human CYP3A4. Pharmaceutical Research. 17(4). 419–426. 70 indexed citations
18.
Iwatsubo, Takafumi, Noriko Hirota, Tsuyoshi Ooie, et al.. (1997). Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacology & Therapeutics. 73(2). 147–171. 384 indexed citations
19.
Spanggord, Ronald J., et al.. (1990). Structure-activity relationship for the intrinsic hepatotoxicity of dinitrotoluenes. Chemical Research in Toxicology. 3(6). 551–558. 11 indexed citations
20.
Steinmetz, Karen L., et al.. (1988). Induction of unscheduled DNA synthesis in primary cultures of rat, mouse, hamster, monkey, and human hepatocytes. Mutation Research/Genetic Toxicology. 206(1). 91–102. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bertrand Rochat Breakdown of academic impact, for papers by Toshiro Niwa Breakdown of academic impact, for papers by Don K. Walker Breakdown of academic impact, for papers by Pankaj B. Desai Breakdown of academic impact, for papers by Adedayo Adedoyin Breakdown of academic impact, for papers by Kimberly K. Adkison Breakdown of academic impact, for papers by Ruth Hyland Breakdown of academic impact, for papers by Michael H. Tarbit Breakdown of academic impact, for papers by Alexander Jetter Breakdown of academic impact, for papers by Nuggehally R. Srinivas
Rankless by CCL
2026